Study shows efficacy of roflumilast in COPD patients

11/20/2013 | Family Practice News

Researchers analyzed data on 1,400 chronic obstructive pulmonary disease patients in the U.S. and found that those who took roflumilast daily had a lower 30-day hospital readmission rate from any cause and experienced fewer monthly COPD exacerbations than those who didn't use the drug. The study was presented at the annual meeting of the American College of Chest Physicians.

View Full Article in:

Family Practice News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC